RIAMET 20 MG/120 MG DISPERSIBLE TABLETS …
RIAMET 20 MG/ 120 mg dispersible tablets . ( artemether and lumefantrine ). PL 00101/0957. UKPAR. TABLE OF CONTENTS. Lay Summary Page 2. Scientific discussion Page 3. Steps taken for assessment Page 40. Steps taken after authorisation Page 41. Summary of Product Characteristics Page 43. Product Information Leaflet Page 44. Labelling Page 45. Annex 1 variation assessment reports Page 47. MHRA PAR RIAMET 20 mg/ 120 mg dispersible tablets (PL 00101/0957) -1- RIAMET 20 MG/ 120 mg dispersible tablets . PL 00101/0957. LAY SUMMARY. This is a summary of the public assessment report (PAR) for RIAMET 20 mg/ 120 mg dispersible tablets . It explains how RIAMET 20 mg/ 120 mg dispersible tablets were assessed and their authorisation recommended as well as their conditions of use. It is not intended to provide practical advice on how to use RIAMET 20 mg/ 120 mg dispersible tablets .
MHRA PAR – Riamet 20 mg/120 mg dispersible tablets (PL 00101/0957) - 1 - RIAMET 20 MG/120 MG DISPERSIBLE TABLETS (Artemether and lumefantrine) PL 00101/0957 . UKPAR . TABLE OF CONTENTS
Download RIAMET 20 MG/120 MG DISPERSIBLE TABLETS …
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: